BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 23890390)

  • 1. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B.
    Tjwa ET; Zoutendijk R; van Oord GW; Biesta PJ; Verheij J; Janssen HL; Woltman AM; Boonstra A
    Liver Int; 2014 Mar; 34(3):396-404. PubMed ID: 23890390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
    Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
    Li J; Sun X; Fang J; Wang C; Han G; Ren W
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
    Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
    PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline.
    Arends P; Rijckborst V; Zondervan PE; Buster E; Cakaloglu Y; Ferenci P; Tabak F; Akarca US; Simon K; Sonneveld MJ; Hansen BE; Janssen HL
    J Viral Hepat; 2014 Dec; 21(12):897-904. PubMed ID: 24444353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss.
    Zheng Q; Zhu YY; Chen J; Liu YR; You J; Dong J; Zeng DW; Gao LY; Chen LH; Jiang JJ
    J Viral Hepat; 2014 Dec; 21(12):909-16. PubMed ID: 24888640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function.
    Boltjes A; van Montfoort N; Biesta PJ; Op den Brouw ML; Kwekkeboom J; van der Laan LJ; Janssen HL; Boonstra A; Woltman AM
    J Infect Dis; 2015 Apr; 211(8):1268-78. PubMed ID: 25362194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
    Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
    Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.
    Zheng Q; Zhu YY; Chen J; Ye YB; Li JY; Liu YR; Hu ML; Zheng YC; Jiang JJ
    Clin Exp Immunol; 2015 Jun; 180(3):499-508. PubMed ID: 25639451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection.
    Tan Z; Li M; Kuang X; Tang Y; Fan Y; Deng G; Wang Y; He D
    J Clin Virol; 2014 Apr; 59(4):228-34. PubMed ID: 24529415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
    Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
    J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection.
    Larsson SB; Malmström S; Hannoun C; Norkrans G; Lindh M
    Virol J; 2015 Dec; 12():213. PubMed ID: 26645241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters.
    Tseng TC; Liu CJ; Yang WT; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1242-9. PubMed ID: 24384028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of circulating CD56
    Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
    Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B.
    Cheng PN; Tsai HW; Chiu YC; Ho CH; Wu IC; Chang TT
    J Clin Virol; 2013 Aug; 57(4):323-30. PubMed ID: 23731848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B.
    Li Y; Wang JJ; Gao S; Liu Q; Bai J; Zhao XQ; Hao YH; Ding HH; Zhu F; Yang DL; Zhao XP
    PLoS One; 2014; 9(2):e86927. PubMed ID: 24520324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.